Neuronetics, Inc. (STIM)
USD 1.37
(5.38%)
USD 1.37
(5.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.03 Million | -30.73 Million | -27.98 Million | -28.39 Million | -30.48 Million | -20.59 Million |
| Net Income | -30.18 Million | -37.15 Million | -31.19 Million | -27.45 Million | -29.04 Million | -24.09 Million |
| Depreciation & Amortization | 2 Million | 1.64 Million | 1.06 Million | 941 Thousand | 1.06 Million | 882 Thousand |
| Deferred income taxes | 7.9 Million | - | - | 622 Thousand | - | 1.39 Million |
| Stock-based compensation | 7.31 Million | 8.74 Million | 7.86 Million | 4.4 Million | 3.43 Million | 1.74 Million |
| Change in working capital | -14.1 Million | -4.77 Million | -6.63 Million | -8.27 Million | -6.91 Million | -1.58 Million |
| Other non-cash items | -4.97 Million | 801 Thousand | 918 Thousand | 1.37 Million | 976 Thousand | 1.06 Million |
| Investing Cash Flow | -1.32 Million | 6.73 Million | -9.83 Million | -730 Thousand | -813 Thousand | -1.01 Million |
| Investments in PPE | -2.36 Million | -3.26 Million | -2.35 Million | -730 Thousand | -813 Thousand | -1.01 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 1.19 Million | 1.11 Million | 324 Thousand | -1.6 Million | -2.61 Million | - |
| Other Investing Activities | -146 Thousand | 8.88 Million | -7.81 Million | 1.6 Million | 2.61 Million | - |
| Financing Cash Flow | 22.69 Million | 207 Thousand | 83 Million | 2.36 Million | 2.42 Million | 97.03 Million |
| Debt repayment | -22.69 Million | -91 Thousand | - | -38.86 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1000.00 | 298 Thousand | 83 Million | 690 Thousand | 2.42 Million | 99.99 Million |
| Other Financing Activities | 45.39 Million | -91 Thousand | 83 Million | 40.53 Million | 2.42 Million | -2.96 Million |
| Accounts receivables | -8.83 Million | -6.31 Million | -3.05 Million | -597 Thousand | -950 Thousand | -1.35 Million |
| Accounts payables | 2.02 Million | -1.96 Million | 276 Thousand | -1.08 Million | 299 Thousand | 606 Thousand |
| Inventory | -1.09 Million | -2.58 Million | -3.44 Million | -945 Thousand | -306 Thousand | -435 Thousand |
| Other working capital | -6.2 Million | 6.09 Million | -415 Thousand | -5.64 Million | -5.95 Million | -401 Thousand |
| Cash at beginning of period | 70.34 Million | 94.14 Million | 48.95 Million | 75.7 Million | 104.58 Million | 29.14 Million |
| Cash at end of period | 59.67 Million | 70.34 Million | 94.14 Million | 48.95 Million | 75.7 Million | 104.58 Million |
| Capital Expenditure | -2.36 Million | -3.26 Million | -2.35 Million | -730 Thousand | -813 Thousand | -1.01 Million |
| Effect of forex changes on cash | -1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -10.66 Million | -23.8 Million | 45.18 Million | -26.75 Million | -28.87 Million | 75.43 Million |
| Free Cash Flow | -34.4 Million | -34 Million | -30.33 Million | -29.12 Million | -31.29 Million | -21.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.83 Million | -7.87 Million | -5.37 Million | -30.18 Million | -9.39 Million | -4.9 Million |
| Depreciation & Amortization | 555 Thousand | 560 Thousand | 503 Thousand | 2 Million | 499 Thousand | 488 Thousand |
| Deferred income taxes | - | - | 89 Thousand | 7.9 Million | 2.54 Million | -266 Thousand |
| Stock-based compensation | 1.56 Million | 1.33 Million | 1.62 Million | 7.31 Million | 1.85 Million | 2.03 Million |
| Change in working capital | 1.73 Million | -6.83 Million | 5.18 Million | -14.1 Million | -5.76 Million | -12.51 Million |
| Other non-cash items | 2.56 Million | 6.57 Million | 106 Thousand | -4.97 Million | 138 Thousand | 134 Thousand |
| Investing Cash Flow | -119 Thousand | 68 Thousand | -563 Thousand | -1.32 Million | 66 Thousand | 5.55 Million |
| Investments in PPE | -616 Thousand | -375 Thousand | -879 Thousand | -2.36 Million | -552 Thousand | -704 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 234 Thousand | 658 Thousand | 1.19 Million | - | - |
| Other Investing Activities | 497 Thousand | 443 Thousand | 316 Thousand | -146 Thousand | 618 Thousand | 6.25 Million |
| Financing Cash Flow | - | - | 22.26 Million | 22.69 Million | - | -62 Thousand |
| Debt repayment | - | - | -22.25 Million | -22.69 Million | - | -62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1000.00 | 1000.00 | - | - |
| Other Financing Activities | - | - | 44.51 Million | 45.39 Million | - | -62 Thousand |
| Accounts receivables | -537 Thousand | -2.66 Million | -898 Thousand | -8.83 Million | -2.47 Million | -9.59 Million |
| Accounts payables | 1.13 Million | -1.98 Million | 1.97 Million | 2.02 Million | -1.52 Million | -907 Thousand |
| Inventory | 516 Thousand | 1.32 Million | 1.64 Million | -1.09 Million | -2.73 Million | 236 Thousand |
| Other working capital | 619 Thousand | -3.51 Million | 2.46 Million | -6.2 Million | 970 Thousand | -2.25 Million |
| Cash at beginning of period | 47.73 Million | 59.67 Million | 35.84 Million | 70.34 Million | 45.9 Million | 55.44 Million |
| Cash at end of period | 42.64 Million | 47.73 Million | 59.67 Million | 59.67 Million | 35.84 Million | 45.9 Million |
| Capital Expenditure | -616 Thousand | -375 Thousand | -879 Thousand | -2.36 Million | -552 Thousand | -704 Thousand |
| Effect of forex changes on cash | - | - | -28.7 Million | -1.00 | - | -546 Thousand |
| Net cash flow / Change in cash | -5.08 Million | -11.94 Million | 23.83 Million | -10.66 Million | -10.05 Million | -9.53 Million |
| Free Cash Flow | -5.58 Million | -12.39 Million | 1.25 Million | -34.4 Million | -10.67 Million | -15.73 Million |
0JAV
WNBZ
PYRUM
MAXQ
2302
SCOUT